We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DKL:NYSEDelek Logistics Partners, L.P. Analysis

Data as of 2026-03-29 - not real-time

$53.12

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Delek Logistics Partners (DKL) trades at $53.12, comfortably above its 20‑day SMA (53.29) and well above the 200‑day SMA (46.51), indicating a longer‑term bullish bias. However, the MACD histogram is negative (-0.046) and the signal line is bearish, while RSI sits at a neutral 50.6, suggesting short‑term momentum is fading. Fundamentally, the company posted a 22% revenue growth year‑over‑year and a solid 33% gross margin, but free cash flow remains negative (-$142 M) and leverage is extreme (debt‑to‑equity > 38,000%). The dividend yield is attractive at 8.41% but the payout ratio exceeds 130%, raising questions about sustainability. The DCF‑derived fair value of $56.27 implies modest upside (~6%) versus the current price, while the market assigns a low beta (0.57) and the sector is experiencing moderate risk.
The recent integration of H2O and Gravity assets expands the Permian footprint and supports the 52‑quarter distribution streak, yet the latest earnings missed expectations and the decreasing volume trend signals waning investor enthusiasm. Balancing the undervalued price relative to peers (P/E 16 vs industry 24) against cash‑flow strain and high leverage suggests a cautious stance: hold with a watch on cash‑flow generation and dividend coverage.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Bearish MACD crossover
  • Earnings miss and negative free cash flow
  • Decreasing volume trend

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Revenue growth and integration of new assets
  • Undervalued relative to DCF and peers
  • High leverage and dividend coverage risk

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustained distribution streak but payout > earnings
  • Long‑term bullish trend (price above SMA200)
  • Sector volatility and regulatory exposure

Key Metrics & Analysis

Financial Health

Revenue Growth21.90%
Profit Margin17.41%
P/E Ratio16.1
ROE847.51%
ROA4.41%
Debt/Equity38920.46
P/B Ratio466.0
Op. Cash Flow$237.1M
Free Cash Flow$-142271248
Industry P/E24.0

Technical Analysis

TrendBullish
RSI50.6
Support$50.88
Resistance$54.91
MA 20$53.29
MA 50$52.26
MA 200$46.51
MACDBearish
VolumeDecreasing
Fear & Greed Index65.98

Valuation

Fair Value$56.27
Target Price$49.00
Upside/Downside-7.76%
GradeUndervalued
TypeBlend
Dividend Yield8.41%

Risk Assessment

Beta0.57
Volatility27.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.